Managed Access AgreementManaged Access Agreement • October 7th, 2024
Contract Type FiledOctober 7th, 2024Primary sources of data collection: Ongoing trial of belzutifan in VHL-associated tumours LITESPARK-004 (MK-6482-004); NHS England routine population-wide cancer data sets, including Systemic Anti-Cancer Therapy data set
Managed Access AgreementManaged Access Agreement • August 28th, 2024
Contract Type FiledAugust 28th, 2024Primary sources of data collection: Ongoing trial of belzutifan in VHL-associated tumours LITESPARK-004 (MK-6482-004); NHS England routine population-wide cancer data sets, including Systemic Anti-Cancer Therapy data set